Tag Archives: Investment
Trials in Pharmaceutical Innovation
Why innovation and access in pharmaceuticals is the key to success
The Global Chinese Citizen
How serving China’s ultra-rich is shaking up the global wealth management industry
The Known Knowns in China’s Marketplace
How the expansion of FIEs has institutionalised CSR practices in China
It’s a gas: Investment opportunities in China’s industrial gas market
Due to their wide-ranging downstream applications and impact on the overall market, industrial gases have been dubbed the ‘blood’ of industry.
Shaping up: creating a better legal environment for investment
Increasing concerns over national security alongside the domestic ambitions of the China Manufacturing 2025 (CM2025) initiative have triggered increasing pessimism among foreign investors regarding China’s attitude towards future foreign investment. In general, though, there are more positive developments than setbacks, say Dr Michael Tan and…
Investing in the future: China’s opportunity to shape a better environment for investment
Max Merkle, Business Manager for the European Chamber’s new Investment Working Group, provides an overview of China’s current investment environment.
China’s Trial Negative List for (domestic and foreign) market access
In recent years, the business community in China has been abuzz with talk of various market access ‘negative lists’ – lists of exceptions to what would otherwise be open market access.
Recent Comments